You are here

Merck

Sanofi, Teva say study results show gut disease drug could be ‘best in class’

BioPharma Dive

Tue, 12/17/24 - 11:59 am

Teva Pharmaceutical

End of the line for Merck's TIGIT, LAG-3 cancer drugs

Pharmaphorum

Tue, 12/17/24 - 11:52 am

immuno-oncology

Lynparza boosts long-term survival in early breast cancer

Pharmaphorum

Thu, 12/12/24 - 11:29 am

ASH 2024: Merck’s new ADC posts positive results in first-line DLBCL

Clinical Trials Arena

Wed, 12/11/24 - 11:21 am

clinical trials

zilovertamab vedotin

BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer

Fierce Biotech

Tue, 12/10/24 - 11:42 am

clinical trials

Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer

Yahoo/Benzinga

Mon, 12/9/24 - 11:06 am

clinical trials

ASH: Merck’s ROR1 drug hits the target in first-line lymphoma

Pharmaphorum

Mon, 12/9/24 - 10:38 am

Chasing Merck, BioNTech and DualityBio post first clinical data on ADC

Fierce Biotech

Fri, 12/6/24 - 09:39 am

Duality Biologics

antibody-drug conjugates

Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study

Fierce Pharma

Mon, 11/25/24 - 09:52 am

clinical trials

FDA finds widely used asthma drug impacts the brain, Reuters reports

CNBC

Fri, 11/22/24 - 11:11 am

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Pharma Voice

Thu, 11/21/24 - 11:12 am

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Fierce Pharma

Wed, 11/20/24 - 08:41 pm

Merck says Keytruda injection on par with approved IV version in trial

CNBC

Tue, 11/19/24 - 11:17 am

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Pharma Voice

Mon, 11/18/24 - 11:12 am

Modifi Biosciences

Merck pays $588M for bispecific to defend Keytruda’s kingdom from emerging threat

Fierce Biotech

Thu, 11/14/24 - 10:07 am

bispecific antibodies

LaNova Medicines

Merck, AstraZeneca report positive data for Koselugo in adults

MSN/Seeking Alpha

Tue, 11/12/24 - 08:49 pm

clinical trials

neurofibromatosis

Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead

Fierce Pharma

Thu, 10/31/24 - 10:50 pm

Moderna and Merck begin trial of mRNA-4157 and Keytruda combination for lung cancer

Clinical Trials Arena

Tue, 10/29/24 - 11:43 am

Moderna Therapeutics

clinical trials

non-small cell lung cancer

Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say

Fierce Biotech

Thu, 10/24/24 - 08:27 pm

Arcus Biosciences

In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines

Fierce Pharma

Wed, 10/23/24 - 10:35 pm

pneumococcal disease

Pages